PANELS

  A Healthy Environment for a Healthy You

Bringing Healthcare Up to Speed: The Good and Bad of IT

 Strategic Financing and Business Development in an Active Healthcare Industry

Consumer Driven Healthcare: Knowing What You Paid For

Sizing Healthcare to Access Underserved Markets

Healthcare Marketing in the Era of Globalization

 




Sizing Healthcare to Access Underserved Markets


This panel will focus on the changes that new miniaturization technologies can have on opportunities to improve global healthcare.  In particular, the discussion will discuss how new technology drives can improve access to health care resource in limited settings, such as rural and/or underserved communities.  Panelists will be asked the following questions:  What markets can benefit the most form such technologies?  Besides technologies themselves, what mechanisms need to be in place in order to make such efforts successful and sustainable in the long run?  What are the trade-offs for quality vs. access with such technologies?  


Moderator
Kara Palamountain, '04, Executive Director of Kellogg Global Health Initiative,
Kellogg School of Management


Panelists
Craig Loomis, Global Marketing Manager, GE Healthcare
Robert Murphy, M.D., John P. Phair Professor of Infectious Diseases at Northwestern University and Director, Global Health Research, Northwestern University
Padraic Romfh, '05, Senior Product Manager, Abbott International
Gloria Young, VP of Global HIV/AIDS Initiative, Becton Dickinson



Craig Loomis, Global Marketing Manager, GE Healthcare

Craig serves as global marketing manager within GE’s X-ray diagnostic imaging department. He covers the performance x-ray segment, which includes several analog and digital X-ray products targeting underserved markets in the world. His responsibilities include understanding the global market dynamics, directing product development, and driving long term product strategy to best serve this market.
 
Craig began his career in GE Healthcare’s Technical Leadership Program where he held various engineering and marketing assignments within diagnostic imaging in Seattle WA and Milwaukee WI. He then progressed through several roles of increasing responsibility in systems engineering and program management before transitioning to a business manager position at Camtronics Medical Systems (now Emageon) directing the company’s program management team for several Cardiac data
management products (image and workflow). Craig then rejoined GE Healthcare as a global marketing manager.
 
Craig holds a MBA from the University of Chicago (Strategy and Marketing) and a Masters of Science in Computer Engineering from Rochester Institute of Technology.


Robert Murphy, M.D., John P. Phair Professor of Infectious Diseases at Northwestern University and Director, Global Health Research, Northwestern University

Dr. Robert L. Murphy is the John P. Phair Professor of Infectious Diseases at Northwestern University where he is also Director, Global Health Research.  He holds academic appointments as Adjunct Professor of Immunology and Infectious Diseases at Harvard School of Public Health and Professeur Associé at the Pierre et Marie Curie Université in Paris.  Dr. Murphy’s primary research interest is in viral infections. His research includes drug development of and the scale up of therapy for AIDS, tuberculosis and malaria in sub-Saharan Africa. He has consulted with numerous pharmaceutical firms and has been involved with the development of over 80% of drugs used to treat HIV and viral hepatitis.
 
Dr. Murphy received his AB from Boston University, an MD from Loyola University and later completed his postgraduate training in Internal Medicine and Infectious Diseases at Northwestern University.

Kara Palamountain, '04, Executive Director of Kellogg Global Health Initiative, Kellogg School of Management

Kara Palamountain is a Research Assistant Professor at the Kellogg School of Management where she serves as the Executive Director of the school’s Global Health Initiative. Kara's research focus is centered on medical diagnostics for infectious diseases in the developing world.

 
In 2003, she began working with Dave Kelso on an initiative to develop and produce affordable HIV diagnostics for the developing world which later obtained funding from the Bill & Melinda Gates Foundation.  In support of this grant, Kara visited nine countries and forty HIV clinics throughout Africa to identify and prioritize the HIV diagnostics that the Kelso laboratory should focus on. She has played a crucial role in defining the appropriate product requirements for resource limited settings and identifying the strategic aspects of introducing a new HIV diagnostic into those areas.


Padraic Romfh, '05, Senior Product Manager, Abbott International

Padraic Romfh is Senior Product Manager for Aluvia and Abbott Laboratories Global HIV Access program.  Padraic concentrates on expanding the availability of Aluvia, a lifesaving antiretroviral drug used in the treatment of HIV/AIDS as well as increasing healthcare infrastructure throughout Africa, Asia, and Latin America.  Padraic’s recent focus has been to pioneer medical education for HIV clinicians in rural and underserved areas.  He has helped to more than triple the number of patients with access to Aluvia and has facilitated training for more than 2000 healthcare professionals across 20 countries in the developing world.
 
Padraic has been at Abbott since 1997 in engineering, project management, and marketing roles in both the diagnostics and pharmaceutical divisions. Padraic earned an MBA from the Northwestern University, Kellogg School of Management, and a BS in Mechanical Engineering from the University of Colorado.

Gloria Young, VP of Global HIV/AIDS Initiative, Becton Dickinson 

As Vice President of the Global HIV/AIDS Initiative at BD Bioscience, Gloria leads the company’s efforts to deploy capabilities in a unified manner in the battle against HIV/AIDS.  She works closely with leaders in the company’s geographic regions, with a particular focus on developing countries in Africa, Asia and Latin America. She is responsible for providing cost-effective CD4 testing solutions as well as Good Laboratory Practices Training on a worldwide basis.

Since joining BD in 1988, Gloria has worked in R&D, overseen clinical trials for HIV/AIDS products, and worked as a Product Manager for the CD4 products. Gloria holds a BS in Biochemistry from University of California at Davis, a MS in Clinical Science from San Francisco State University, and a Masters in Business Administration from Pepperdine University.